VEGFR-2-IN-6
VEGFR-2-IN-6 (example 64) is a VEGFR2 inhibitor (angiogenesis modulator), which is extracted from patent WO 02/059110[1].
Product Specifications
CAS Number
[444731-47-9]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/vegfr-2-in-6.html
Concentration
10mM
Purity
99.89
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=S(C1=CC(NC2=NC=CC(N(C)C3=CC4=C(C=C3)C(C)=NN4)=N2)=CC=C1C)(N)=O
Molecular Formula
C20H21N7O2S
Molecular Weight
423.49
Precautions
H302, H315, H319, H335
References & Citations
[1]Glaxo Wellcome House, et al. PYRIMIDINEAMINES AS ANGIOGENESIS MODULATORS. Patent WO 02/059110.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items